MindWalk Holdings HYFT
NASDAQ HYFT
$1.32 -0.01 (-0.75%)
At close: Sep 4, 2026 · 4:00 PM EDT

MindWalk Holdings (HYFT) Enterprise Value (2020 - 2026)

MindWalk Holdings (HYFT) posted quarterly Enterprise Value of -$8.4 million for Q2 2026, down 10.29% year-over-year from -$9.3 million in Q2 2025, and up 17.45% quarter-over-quarter from -$10.1 million in Q1 2026.

Analysis

MindWalk Holdings (HYFT) Enterprise Value (2020 - 2026) Analysis & Trends

MindWalk Holdings (HYFT) has reported Enterprise Value for 7 consecutive years, with -$8.4 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Enterprise Value fell 10.29% year-over-year to -$8.4 million; the TTM figure through Apr 2026 stood at -$8.4 million (down 10.29% YoY), while the FY2026 annual figure was -$8.4 million, down 7.96% from the prior year.
  • Enterprise Value rose to -$8.4 million in Q2 2026 per HYFT's latest filing, from -$10.1 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$2.6 million in Q2 2024 and bottomed at -$26.1 million in Q1 2022.
  • Historically, Enterprise Value has averaged -$9.1 million across 5 years, with a median of -$8.0 million in 2026.
  • Annual changes were most pronounced in 2023 — Enterprise Value jumped 73.94% — and 2025, when it plunged 348.79%.
  • MindWalk Holdings' Enterprise Value stood at -$11.3 million in 2022, then soared by 60.3% to -$4.5 million in 2023, then surged by 41.1% to -$2.7 million in 2024, then tumbled by 348.79% to -$11.9 million in 2025, then climbed by 29.66% to -$8.4 million in 2026.
  • Business Quant data shows HYFT's Enterprise Value at -$8.4 million in Q2 2026, -$10.1 million in Q1 2026, and -$11.9 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 MindWalk Holdings 61.22 Mn 52.95 Mn 1.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 47.31 Mn
Jan 31, 2026 43.94 Mn
Oct 31, 2025 50.53 Mn
Jul 31, 2025 51.86 Mn
Apr 30, 2025 7.13 Mn
Jan 31, 2025 3.37 Mn
Oct 31, 2024 10.20 Mn
Jul 31, 2024 18.34 Mn
Apr 30, 2024 31.87 Mn
Jan 31, 2024 40.69 Mn
Oct 31, 2023 53.21 Mn
Jul 31, 2023 58.02 Mn
Apr 30, 2023 58.20 Mn
Jan 31, 2023 78.17 Mn
Oct 31, 2022 86.51 Mn
Jul 31, 2022 68.32 Mn
Apr 30, 2022 85.74 Mn
Jan 31, 2022 92.40 Mn
Oct 31, 2021 95.43 Mn
Jul 31, 2021 93.00 Mn